Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Keyword Search Criteria: Subgroup returned 23 record(s)
|
Sunday, 07/30/2017
|
Subgroup Inference for Multiple Treatments and Multiple Endpoints
Brad Carlin, University of Minnesota; Patrick Schnell, University of Minnesota; Peter Mueller, UT Austin; Qi Tang, AbbVie, Inc.
2:05 PM
|
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Richard C. Zink, JMP Life Sciences, SAS Institute, Inc.
2:05 PM
|
Semiparametric Benefiting Subgroup Identification via Credible Subgroups
Patrick Schnell, University of Minnesota; Qi Tang, AbbVie, Inc.; Peter Mueller, UT Austin; Brad Carlin, University of Minnesota
2:20 PM
|
Monday, 07/31/2017
|
An Adaptive Subgroup-Identification Enrichment Design
Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Florica Constantine, Johns Hopkins University
11:15 AM
|
Methods of Biomarker and Subgroup Identification for Personalized Medicine
Ilya Lipkovich, QuintilesIMS; Bohdana Ratitch , QuintilesIMS; Alex Dmitrienko, Mediana Inc
2:05 PM
|
Measuring Differential Treatment Benefit Across Marker Specific Subgroups: The Choice of Outcome Scale
Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center; Jaya Satagopan, Memorial Sloan Kettering Cancer Center
2:25 PM
|
ASID: A Bayesian Adaptive Subgroup-Identification Enrichment Design
Florica Constantine, Johns Hopkins University; Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Zhilin Jin, Johns Hopkins University
2:50 PM
|
Tuesday, 08/01/2017
|
Subgroup Analyzes with Survival Data in Retrospective Cohort Studies
Rima Izem, Food and Drug Administration; Jiemin Lao, Sphere Institute; Mao Hu, Acumen LLC; Yuqin Wei, Sphere Institute; Michael Wernecke, Acumen LLC; Jeffrey A Kelman, Centers for Medicaid and Medicare Services (CMS); David J Graham, Food and Drug Administration
|
Subgroup Analyzes with Survival Data in Retrospective Cohort Studies
Rima Izem, Food and Drug Administration; Jiemin Lao, Sphere Institute; Mao Hu, Acumen LLC; Yuqin Wei, Sphere Institute; Michael Wernecke, Acumen LLC; Jeffrey A Kelman, Centers for Medicaid and Medicare Services (CMS); David J Graham, Food and Drug Administration
10:50 AM
|
Cluster-Enabled Inference for Subgroup Comparison of Copy Number Profiles Using Bayesian Change-Point Models for Profile Characterization
Miranda Lynch, Los Alamos National Laboratory
12:05 PM
|
Wednesday, 08/02/2017
|
Bayesian Subgroup Finding by Stochastic Optimization
Arinjita Bhattacharyya, University of Louisville; LURDES INOUE INOUE, University of Washington; Peter Mueller, UT Austin; Riten Mitra, UNIVERSITY OF LOUISVILLE
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
|
Identification of Subgroups with Heterogeneous Treatment Effect in Dose-Response Studies
Bjorn Bornkamp, Novartis Pharma AG; Marius Thomas, Novartis
8:35 AM
|
Improving Subgroup Identification: Type I Error Control, Power, and the Quality of Subgroups
Lei Shen, Eli Lilly and Company
8:55 AM
|
Subgroup Identification of Early Preterm Birth (EPTB): Informing a Future Prospective Enrichment Clinical Trial Design
Chuanwu Zhang, University of Kansas Medical Center
9:05 AM
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
9:10 AM
|
Sample Size Calculation in Confirmatory Subgroup Analyses
Dong Xi, Novartis Pharmaceuticals Corporation; Frank Bretz, Novartis AG; Ekkehard Glimm, Novartis
9:15 AM
|
Test for a Change Point in the Linear Combination of Risk Predictors
Ju Hee Cho, Fred Hutchinson Cancer Research Center; Ying Huang, Fred Hutchinson Cancer Research Center
9:20 AM
|
Optimally Identify High Value Subgroups of Patients via Baseline Covariates
Florence Yong, Pfizer Inc.; Lu Tian, Stanford University
9:35 AM
|
Estimand in Evaluating Predictive or Selection Markers Using Enrichment Design in Clinical Trials
Jingjing Ye, FDA
9:55 AM
|
A Bayesian Approach Developed for Single Arm Studies Using Performance Goals with Subgroups
Wei-Chen Chen, FDA/CDRH; Nelson Lu, CDRH/FDA
11:15 AM
|
Subgroup Analyzes from Multiple Imputed Data Sets
Tianyue Zhou; Zhiying Qiu, Sanofi; Meehyung Cho, Sanofi; Hui Quan, Sanofi
11:50 AM
|
Evaluation of Subgroup-Specific Incremental Value of New Markers for Treatment Selection
Ying Huang, Fred Hutchinson Cancer Research Center
11:55 AM
|
|
|